Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
DCOY
$1.61
+3.87%
DCOY
· Decoy Therapeutics Inc.
$1.61
+0.06 (+3.87%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The lack of revenue from product sales to date and recurring losses from operations since its inception raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$1.29M
Shares
655,185
Volume · Oct 7
84.33K
Avg daily vol (3M)
2.14M
All webcasts
Earnings call · FY2020 Q3
Decoy Therapeutics Inc. (DCOY) Q3 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$1.38M
+57.5% YoY
Diluted EPS
-$3600.00
Net income
-$1.72M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 12, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 12, 2020 · complete as-filed document